bioRxiv Science⌕ Search

Biology subjects

Vranken, W. F.

Publications and source records attributed to Vranken, W. F..

At least 19 recordsLinked to original sources

Polyploid Achromatium sp. expresses protein variants based on environmental cues

Achromatium spp. are giant bacteria harboring hundreds of non-clonal chromosomes per cell. The allelic divergence they exhibit could be a mechanism to enable fine-tuned responses to environmental changes, enabling this organism to broaden its ecological range. However, while ubiquitous in freshwater and marine environments, Achromatium has not been obtained in culture, leaving the role and functioning of its genomic and proteomic diversity poorly understood. Here, we incubated freshly collected freshwater Achromatium under three temperature conditions to conduct comparative mass spectrometry-based proteomics experiments. These were interpreted against an Achromatium-specific protein atlas developed from curated published and new assemblies from marine and freshwater environments. This de novo assembled atlas allowed a twenty-fold increase in the number of identified proteins compared to mass spectrometry data searches against the UniProt database. Predicted proteins from the Achromatium atlas were grouped into orthologs, 5% of which showed temperature-associated detection of distinct protein variants within the group. This provides the first indication that Achromatium uses distinct protein variants under different environmental conditions, enabling it to swiftly respond to environmental changes through differential expression from its cache of chromosomes.

microbiology↗

Beyond benchmark accuracy: machine-learning turnover-number predictors require system-level validation

Enzyme turnover numbers (kcat) are essential for kinetic models and enzyme-constrained genome-scale metabolic models (ecGEMs), but measured values are sparse and therefore increasingly estimated using machine learning (ML). Although these predictors are commonly evaluated by global regression metrics, their practical utility depends on how errors propagate through downstream models. We benchmarked six current kcat predictors on a curated BRENDA-derived dataset and five of them on EnzyExtract. To assess the influence of training-set proximity, we compared each benchmark dataset with the available training data for each predictor. We then used the predicted kcat values to parameterize ecGEMs of Saccharomyces cerevisiae and evaluated growth predictions across 19 conditions. We find that benchmark accuracy is moderate even on the BRENDA-derived dataset and drops sharply on EnzyExtract, where all predictors achieve R2 values of 0.20 or lower. This decline is accompanied by substantially lower overlap between the benchmark and training datasets, with exact sequence matches ranging from 24% to 78% for BRENDA, compared with 9% to 26% for EnzyExtract. However, that overlap alone does not explain differences in generalization across predictors. Moreover, downstream performance is also not explained by benchmark ranking. Across 19 conditions, none of the tool-specific ecGEMs consistently reproduces the experimentally observed variation in growth. In glucose minimal medium, the weakest benchmark performer yields the most accurate growth prediction in the downstream ecGEMs, whereas higher-ranked predictors produce larger deviations in growth. We trace this mismatch to localized errors at high-leverage positions in yeast's metabolic network, where underpredicted mitochondrial ADP/ATP carrier turnover numbers restrict adenine nucleotide exchange and impose an apparent limitation on cytosolic ATP supply. Relaxing this constraint shifts predicted growth toward the experimental reference. Thus, ML-derived kcat values can affect not only quantitative growth predictions but also the phenotype a mechanistic model appears to identify. These results argue for application-driven validation of biological parameter predictors in the downstream systems they are intended to support.

bioinformatics↗

Scop3P-Toolkit: executable structure-aware workflows linking PTMs, peptides, and mutations to protein function

Post-translational modifications (PTMs) and genetic variants regulate protein function, signalling, and disease, but their interpretation requires integration of sequence annotations with structural, interaction, and biophysical context. Although resources such as Scop3P, UniProt, the Protein Data Bank, and AlphaFold provide extensive annotations and structural information, integrating these data into reproducible structure-aware analyses still requires custom scripting and manual coordination between multiple independent tools. To address this challenge, we developed Scop3P-Toolkit, an open-source executable analytical environment for interactive analysis of PTMs, mutations, and proteomics-derived peptides in their structural context. The toolkit integrates protein annotation retrieval with structural mapping, residue interaction network analysis, comparative structural analysis, and residue-level biophysical profiling within a unified framework. Experimentally supported phosphosites, phosphopeptides, and phosphoproteomics evidence are provided for human proteins through Scop3P, with optional integration of curated UniProt PTM annotations. UniProt-derived PTMs, sequence features, and genetic variants are available for proteins from any species, extending the framework beyond the human phosphoproteome. Scop3P-Toolkit supports structure-centric analyses including interpretation of PTMs and disease-associated variants, analysis of residue interaction networks and their rewiring across alternative conformations, structural localisation of peptides, and exploration of protein-protein, protein-ligand, and host-pathogen interfaces. Interactive visualisation links sequence annotations, three-dimensional structures, residue interaction networks, and biophysical profiles, enabling coordinated exploration across multiple molecular representations. The toolkit is distributed as Jupyter notebooks, browser-based Voila applications, and a Galaxy interactive tool, providing transparent, accessible, and reproducible workflows for both computational and experimental researchers. By integrating biological annotation resources into executable, structure-aware workflows, Scop3P-Toolkit enables reproducible interpretation of PTMs, mutations, and proteomics data.

bioinformatics↗

Scop3P in 2026: an expanded proteomics-informed resource contextualizing phosphorylation sites through sequence, structure, mutation, and experimental provenance

Protein phosphorylation is a central regulatory mechanism controlling protein activity, interactions, and cellular signalling, and its dysregulation is implicated in numerous diseases. Advances in mass spectrometry-based phosphoproteomics have led to a rapid expansion in the number of reported phosphorylation sites; however, interpretation of these data remains challenging due to fragmented evidence, limited structural context, and the lack of uniform experimental provenance across resources. Interpretation is further complicated by the fact that the biological meaning of reported phosphosites can vary substantially across tissues, cell lines, perturbations, and disease settings. Here, we present a major update of Scop3P, a proteomics-informed knowledgebase that contextualizes human phosphorylation sites within integrated sequence, structural, biophysical, evolutionary, and mutational frameworks. The current release incorporates uniformly reprocessed human phosphoproteomics data from 116 PRIDE datasets alongside curated UniProt annotations, retaining peptide-spectrum matches, site localization confidence, and direct links to primary mass spectrometry evidence via Universal Spectrum Identifiers. This integration yields 152,350 unique serine, threonine, and tyrosine phosphorylation sites across 16,533 human proteins, supported by full experimental provenance. Beyond site identification, Scop3P provides residue-level contextual annotations derived from experimentally determined protein structures and proteome-wide AlphaFold models, enabling near-complete structural coverage of phosphorylation sites. Structural context is further complemented by residue-level biophysical, evolutionary, and mutational annotations, supporting integrated assessment of phosphorylation in functional and disease-related settings. The current release also introduces residue interaction network representations derived from AlphaFold-predicted structures, capturing spatial connectivity and local interaction environments of phosphorylation and mutation sites. A redesigned web interface enables interactive exploration through coordinated 1D, 2D, 2.5D, and 3D visualizations, peptide-level coverage views, and direct access to original spectra via PRIDE. By bridging experimental phosphoproteomics with structural, functional, and disease-related context, Scop3P provides a scalable and provenance-aware resource for phosphosite interpretation, hypothesis generation, and data-driven modelling of phosphorylation-dependent regulation.

bioinformatics↗

Constrained protein Large Language Model illustrated in protein stability, function and epistasis

Our understanding of protein function and evolution is largely based on the relationship between amino acid sequence and overall fold, now effectively captured by computational models. Yet predicting how mutations--shaped by epistasis--alter protein behavior, especially in dynamic or structurally ambiguous regions, remains difficult. Here we present D2D, which combines a self-supervised protein language model with protein-specific evolutionary information to predict mutational effects using little to no task-specific labeled data. D2D captures long-range epistatic interactions, accurately predicts single and higher-order mutation effects on protein thermostability and binding, without being trained on the task. When fine-tuned, D2D outperforms state-of-the-art methods on latent driver cancer mutations and co-occurring proliferation-enhancing mutations across independent experimental studies. Unlike most existing approaches, D2D avoids biases linked to solvent accessibility or to multiple sequence alignment depth and quality, making it particularly effective for disordered or surface binding regions where structure-based predictors typically falter. Overall, D2D provides a general framework for modeling mutational effects in proteins with limited experimental or structural information.

bioinformatics↗

The NMR Exchange Format (NEF): Specification and Applications

The NMR Exchange Format (NEF) is a community-driven standard for representing NMR experimental data in a consistent, interoperable, and machine-readable form. Built on the STAR syntax, NEF provides a structured framework for storing and exchanging chemical shifts, peak lists, various types of structural restraints, and related metadata, thus allowing for data exchange across software platforms. By enabling direct, lossless transfer of information, NEF simplifies multi-software workflows, improves reproducibility, and supports FAIR (Findable, Accessible, Interoperable, Reusable) data principles. We describe the NEF specification, its current implementation across commonly used NMR software packages, and its application in areas including biomolecular structure determination, metabolomics, and ligand screening. Testing demonstrates that NEF can be used to exchange complete datasets between programs without loss of information or functionality. We also outline recent developments and future directions, such as inclusion of NMR relaxation data and support for non-standard residue topologies. NEFs growing adoption highlights its potential as a unifying standard for NMR data, enabling more efficient, transparent and collaborative research.

biochemistry↗

Assessing the relation between protein phosphorylation, AlphaFold3 models and conformational variability

Proteins perform diverse functions critical to cellular processes. Transitions between functional states are often regulated by post-translational modifications (PTMs) such as phosphorylation, which dynamically influence protein structure, function, folding, and interactions. Dysregulation of PTMs can therefore contribute to diseases such as cancer and Alzheimers. However, the structure-function relationship between proteins and their modifications remains poorly understood due to a lack of experimental structural data, the inherent diversity of PTMs, and the dynamic nature of proteins. Recent advances in deep learning, particularly AlphaFold, have transformed protein structure prediction with near-experimental accuracy. However, it remains unclear whether these models can effectively capture PTM-driven conformational changes, such as those induced by phosphorylation. Here, we systematically evaluated AlphaFold models (AF2, AF3-non phospho, and AF3-phospho) to assess their ability to predict phosphorylation-induced structural diversity. By analysing experimentally derived conformational ensembles, we found that all models predominantly aligned with dominant structural states, often failing to capture phosphorylation-specific conformations. Despite its phosphorylation-aware design, AF3-phospho predictions provided only modest improvement over AF2 and AF3-non phospho predictions. Our findings highlight key challenges in modelling PTM-driven structural landscapes and underscore the need for more adaptable structure prediction frameworks capable of capturing modification-induced conformational variability.

bioinformatics↗

GPCRchimeraDB: A database of chimeric G-Protein Coupled Receptors (GPCRs) to assist their design

G protein-coupled receptors (GPCRs) are membrane proteins crucial to numerous diseases, yet many remain poorly characterized and untargeted by drugs. Chimeric GPCRs have emerged as valuable tools for elucidating GPCR function by facilitating the identification of signaling pathways, resolving structures, and discovering novel ligands of poorly understood GPCRs. Such chimeric GPCRs are obtained by merging a well- and less-well-characterized GPCR at the intracellular limits of their transmembrane regions or intracellular loops, leveraging knowledge transfer from the well-characterized GPCR. However, despite the 212 chimeric GPCRs engineered to date, the design process remains largely trial-and-error and lacks a standardized approach. To address this gap, we introduce GPCRchimeraDB (https://www.bio2byte.be/gpcrchimeradb/), the first comprehensive database dedicated to chimeric GPCRs. It catalogs 212 chimeric receptors, identified through literature review, and includes 1,755 class A natural GPCRs, enabling connections between chimeras and their parent receptors while facilitating the exploration of novel parent combinations. Both chimeric and natural GPCR entries are extensively described at the sequence, structural, and biophysical level through a range of visualization tools, with annotations from resources like UniProt and GPCRdb and predictions from AlphaFold2 and b2btools. Additionally, GPCRchimeraDB offers a GPCR sequence aligner and a feature comparator to investigate differences between natural and chimeric receptors. It also provides design guidelines to support rational chimera engineering. GPCRchimeraDB is therefore a resource to facilitate and optimize the design of new chimeras, so helping to gain insights into poorly characterized receptors and contributing to advances in GPCR therapeutic development.

bioengineering↗

Cryo-EM structures of the MnmE-MnmG complex reveal large conformational changes and provide new insights into the mechanism of tRNA modification

MnmE and MnmG form a conserved protein complex responsible for the addition of a 5-carboxymethylaminomethyl (cmnm5) group onto the wobble uridine of several tRNAs. Within this complex, both proteins collaborate intensively to catalyze a tRNA modification reaction that involves glycine as a substrate in addition to three different cofactors, with FAD and NADH binding to MnmG and methylenetetrahydrofolate (5,10-CH2-THF) to MnmE. Without structures of the MnmEG complex it remained enigmatic how these substrates and co-factors can be brought together in a concerted manner. Prior SAXS data suggested that the MnmE (2) and MnmG ({beta}2) homodimers can adopt either an 2{beta}2 or 4{beta}2 complex, depending on the nucleotide state of MnmE. Here, we report the cryo-EM structures of the MnmEG complex in the 2{beta}2 and 4{beta}2 oligomeric states. These structures reveal that MnmE undergoes large conformational changes upon interaction with MnmG, resulting in an asymmetric MnmE dimer. In particular, the functionally important C-terminal helix of MnmE relocates from the 5,10-CH2-THF binding pocket of MnmE to the FAD binding pocket of MnmG, thus suggesting a mechanism for the transfer of an activated methylene group from one active site to the other. Together, these findings provide crucial new insights into the MnmEG-catalyzed reaction. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=89 SRC="FIGDIR/small/625835v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@144e41forg.highwire.dtl.DTLVardef@1dce537org.highwire.dtl.DTLVardef@14c9359org.highwire.dtl.DTLVardef@5dec04_HPS_FORMAT_FIGEXP M_FIG C_FIG

biochemistry↗

Deciphering the RNA recognition by Musashi-1 to design protein and RNA mutants for in vitro and in vivo applications

RNA Recognition Motifs (RRMs) are essential post-transcriptional regulators of gene expression in eukaryotic cells. The Human Musashi-1 (MSI-1) is an RNA-binding protein that recognizes (G/A)U1-3AGU and UAG sequences in diverse RNAs through two RRMs and regulates the fate of target RNA. Here, we combined structural biology and computational approaches to analyse the binding of the RRM domains of human MSI-1 with single-stranded and structured RNAs ligands. We used our recently developed computational tool RRMScorer to design a set of mutants of the MSI-1 protein to bind novel RNA sequences to alter the binding selectivity. The in-silico predictions of the designed protein-RNA interactions are assessed by NMR and SPR. These experiments also are used to study the competition of the two RRM domains of MSI-1 for the same binding site within linear and harpin RNA. Our experimental results confirm the in-silico designed interactions, thus opening the way for the development of new biomolecules for in vitro and in vivo studies and downstream applications.

biophysics↗

In-silico identification of archaeal DNA-binding proteins

The rapid advancement of next-generation sequencing technologies has generated an immense volume of genetic data. However, this data is unevenly distributed, with well-studied organisms being disproportionately represented, while other organisms, such as from archaea, remain significantly underexplored. The study of archaea is particularly challenging due to the extreme environments they inhabit and the difficulties associated with culturing them in the laboratory. Despite these challenges, archaea likely represent a crucial evolutionary link between eukaryotic and prokaryotic organisms, and their investigation could shed light on the early stages of life on Earth. Yet, a significant portion of archaeal proteins are annotated with limited or inaccurate information. Among the various classes of archaeal proteins, DNA-binding proteins are of particular importance. While they represent a large portion of every known proteome, their identification in archaea is complicated by the substantial evolutionary divergence between archaeal and the other better studied organisms. To address the challenges of identifying DNA-binding proteins in archaea, we developed Xenusia, a neural network-based tool capable of screening entire archaeal proteomes to identify DNA-binding proteins. Xenusia has proven effective across diverse datasets, including metagenomics data, successfully identifying novel DNA-binding proteins, with experimental validation of its predictions. Xenusia is available as a PyPI package, with source code accessible at https://github.com/grogdrinker/xenusia, and as a Google Colab web server application at https://colab.research.google.com/drive/1c4eb4sEz8OsBqHL62XDFrqmwa7CxImww?usp=sharing.

bioinformatics↗

Gradations in protein dynamics captured by experimental NMR are not well represented by AlphaFold2 models and other computational metrics

The advent of accurate methods to predict the fold of proteins initiated by AlphaFold2 is rapidly changing our understanding of proteins and helping their design. However, these methods are mainly trained on protein structures determined with X-ray diffraction, where the protein is packed in crystals at often cryogenic temperatures. They can therefore only reliably cover well-folded parts of proteins that experience few, if any, conformational changes. Experimentally, solution nuclear magnetic resonance (NMR) is the experimental method of choice to gain insight into protein dynamics at near physiological conditions. Computationally, methods such as molecular dynamics and Normal Mode Analysis (NMA) allow the estimation of a proteins intrinsic flexibility based on a single protein structure. This work addresses, on a large scale, the relationships for proteins between the AlphaFold2 pLDDT metric, the observed dynamics in solution from NMR metrics, interpreted MD simulations, and the computed dynamics with NMA from single AlphaFold2 models and NMR ensembles. We observe that these metrics agree well for rigid residues that adopt a single well-defined conformation, which are clearly distinct from residues that exhibit dynamic behavior and adopt multiple conformations. This direct order/disorder categorisation is reflected in the correlations observed between the parameters, but becomes very limited when considering only the likely dynamic residues. The gradations of dynamics observed by NMR in flexible protein regions are therefore not represented by these computational approaches. Our results are interactively available for each protein from https://bio2byte.be/af_nmr_nma/.

bioinformatics↗

Effects of phosphorylation on protein backbone dynamics and conformational preferences

Phosphorylations are the most common and extensively studied post-translational modification (PTM) of proteins in eukaryotes. They constitute a major regulatory mechanism, modulating protein function, protein-protein interactions, as well as subcellular localization. Phosphorylation sites are preferably located in intrinsically disordered regions and have been shown to trigger structural rearrangements and order-to-disorder transitions. They can therefore have a significant effect on protein backbone dynamics or conformation, but only sparse experimental data are available. To obtain a more general description of how and when phosphorylations have a significant effect on protein behavior, molecular dynamics (MD) currently provides the only suitable framework to study these effects at a large scale in atomistic detail. This study develops a systematic MD simulation framework to explore the influence of phosphorylations on the local backbone dynamics and conformational propensities of proteins. Through a series of glycine-backbone peptides, we studied the effects of amino acid residues including the three most common phosphorylations (Ser, Thr, and Tyr), on local backbone dynamics and conformational propensities. We further extended our study to investigate the interactions of all such residues between position i to positions i+1, i+2, i+3, and i+4 in such peptides. The final dataset is comprised of structural ensembles for 3,393 sequences with more than 1 {micro}s of sampling for each ensemble. To validate the relevance of the results, the structural and conformational properties extracted from the MD simulations are compared to NMR data from the Biological Magnetic Resonance Data Bank. The systematic nature of this study enables the projection of the gained knowledge onto any phosphorylation-site in the proteome and provides a general framework for the study of further PTMs. The full dataset is publicly available, as a training and reference set.

bioinformatics↗

Protein kinase Sut1 from the Crenarchaeon Sulfolobus acidocaldarius displays tyrosine phosphorylation activity

Protein phosphorylation is a key cellular signaling mechanism that exists in all life forms. Unlike Bacteria and Eukarya, in which protein phosphorylation has thoroughly been studied, post-translational modification by means of phosphorylation have only been limitedly explored in Archaea. A previous study of the phosphoproteome of the model Crenarchaeon Sulfolobus acidocaldarius revealed a widespread occurrence of protein phosphorylation, especially on tyrosine residues. Moreover, several (putative) transcription factors, including AbfR1 and FadR, were previously shown to be phosphorylated on tyrosine residues, a phenomenon that is directly linked to a phosphorylation-mediated regulation of these transcription factors. Despite this potentially important role for tyrosine phosphorylation in S. acidocaldarius, to our knowledge, a kinase capable of directly phosphorylating tyrosine residues has not yet been identified in this organism, neither in Archaea as a whole. Here, we identify and characterize a protein kinase in S. acidocaldarius, Sut1, which displays tyrosine phosphorylation activity in vitro and represents a novel protein kinase family that is widespread in different archaeal organisms.

microbiology↗

Combining evolution and protein language modelsfor an interpretable cancer driver mutationprediction with D2Deep

The mutations driving cancer are being increasingly exposed through tumor-specific genomic data. However, differentiating between cancer-causing driver mutations and random passenger mutations remains challenging. State-of-the-art homology-based predictors contain built-in biases and are often ill-suited to the intricacies of cancer biology. Protein Language Models have successfully addressed various biological problems but have not yet been tested on the challenging task of cancer driver mutation prediction at large scale. Additionally, they often fail to offer result interpretation, hindering their effective use in clinical settings. The AI-based D2Deep method we introduce here addresses these challenges by combining two powerful elements: i) a non-specialized protein language model that captures the makeup of all protein sequences and ii) protein-specific evolutionary information that encompasses functional requirements for a particular protein. D2Deep relies exclusively on sequence information, outperforms state-of-the-art predictors and captures intricate epistatic changes throughout the protein caused by mutations. These epistatic changes correlate with known mutations in the clinical setting and can be used for the interpretation of results. The model is trained on a balanced, somatic training set and so effectively mitigates biases related to hotspot mutations compared to state-of-the-art techniques. The versatility of D2Deep is illustrated by its performance on non-cancer mutation prediction, where most variants still lack known consequences. D2Deep predictions and confidence scores are available via https://tumorscope.be/d2deep to help with clinical interpretation and mutation prioritization.

bioinformatics↗

Data-driven probabilistic definition of the low energy conformational states of protein residues

Protein dynamics and related conformational changes are essential for their function but difficult to characterise and interpret. Amino acids in a protein behave according to their local energy landscape, which is determined by their local structural context and environmental conditions. The lowest energy state for a given residue can correspond to sharply defined conformations, e.g., in a stable helix, or can cover a wide range of conformations, e.g., in intrinsically disordered regions. A good definition of such low energy states is therefore important to describe the behavior of a residue and how it changes with its environment. We propose a data-driven probabilistic definition of six low energy conformational states typically accessible for amino acid residues in proteins. This definition is based on solution NMR information of 1,322 proteins through a combined analysis of structure ensembles with interpreted chemical shifts. We further introduce a conformational state variability parameter that captures, based on an ensemble of protein structures from molecular dynamics or other methods, how often a residue moves between these conformational states. The approach enables a different perspective on the local conformational behavior of proteins that is complementary to their static interpretation from single structure models.

bioinformatics↗

Repurposing the mammalian RNA-binding protein Musashi-1 as an allosteric translation repressor in bacteria

The RNA recognition motif (RRM) is the most common RNA-binding protein domain identified in nature. However, RRM-containing proteins are only prevalent in eukaryotic phyla, in which they play central regulatory roles. Here, we engineered an orthogonal post-transcriptional control system of gene expression in the bacterium Escherichia coli with the mammalian RNA-binding protein Musashi-1, which is a stem cell marker with neurodevelopmental role that contains two canonical RRMs. In the circuit, Musashi-1 is regulated transcriptionally and works as an allosteric translation repressor thanks to a specific interaction with the N-terminal coding region of a messenger RNA and its structural plasticity to respond to fatty acids. We fully characterized the genetic system at the population and single-cell levels showing a significant fold change in reporter expression, and the underlying molecular mechanism by assessing the in vitro binding kinetics and in vivo functionality of a series of RNA mutants. The dynamic response of the system was well recapitulated by a bottom-up mathematical model. Moreover, we applied the post-transcriptional mechanism engineered with Musashi-1 to specifically regulate a gene within an operon, to implement combinatorial regulation, and to reduce protein expression noise. This work illustrates how RRM-based regulation can be adapted to simple organisms, thereby adding a new regulatory layer in prokaryotes for translation control.

synthetic biology↗

A panoramic perspective on human phosphosites

Protein phosphorylation is the most common post-translational reversible modification of proteins and is key in the regulation of many cellular processes. Due to this importance, phosphorylation is extensively studied, resulting in the availability of a large amount of mass spectrometry based phospho-proteomics data. Here, we leverage the information in these large-scale phospho-proteomics datasets, as contained in Scop3P, to analyze and characterize proteome-wide protein phosphorylation sites (P-sites). First, we set out to differentiate correctly observed P-sites from false positive sites using five complementary site properties. We then describe the context of these P-sites in terms of protein structure, solvent accessibility, structural transitions and disorder, and biophysical properties. We also investigate the relative prevalence of disease-linked mutations on and around P-sites. Moreover, we also assess structural dynamics of P-sites in their phosphorylated and unphosphorylated state. Our study shows that the residues that gets phosphorylated are more flexible than their equivalent non-phosphorylated residues. Our structural and biophysical analyses of P-sites in solvent inaccessible (buried) regions of proteins show that these sites are primarily found in multi-site phospho-proteins, where highly dynamic structural transitions can occur upon binding with another protein. Finally, our analysis of the biophysical properties of P-site mutations shows that P-site mutations that occur in structurally rigid regions are more often involved in disease.

bioinformatics↗